Liesly Lee

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study

Nir Lipsman, Michael L. Schwartz, Yuexi Huang et al. · The Lancet Neurology · 2013 · 595 citations

Medical Ultrasound, Essential Tremor, Medical Imaging +4

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

Luanne M. Metz, David K.B. Li, Anthony Traboulsee et al. · New England Journal of Medicine · 2017 · 184 citations · Full text

A Citywide Prehospital Protocol Increases Access to Stroke Thrombolysis in Toronto

David J. Gladstone, Lance H. Rodan, Demetrios J. Sahlas et al. · Stroke · 2009 · 102 citations · Full text